[go: up one dir, main page]

EP1044139A1 - Fermetures plastiques bactericides pour recipients a boissons - Google Patents

Fermetures plastiques bactericides pour recipients a boissons

Info

Publication number
EP1044139A1
EP1044139A1 EP99955165A EP99955165A EP1044139A1 EP 1044139 A1 EP1044139 A1 EP 1044139A1 EP 99955165 A EP99955165 A EP 99955165A EP 99955165 A EP99955165 A EP 99955165A EP 1044139 A1 EP1044139 A1 EP 1044139A1
Authority
EP
European Patent Office
Prior art keywords
closure
antibiotic
silver
zeolite
top wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99955165A
Other languages
German (de)
English (en)
Other versions
EP1044139A4 (fr
Inventor
Amy Stahl
John E. Barry
Jeffrey A. Trogolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AgION Technologies LLC
Original Assignee
HealthShield Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HealthShield Technologies LLC filed Critical HealthShield Technologies LLC
Publication of EP1044139A1 publication Critical patent/EP1044139A1/fr
Publication of EP1044139A4 publication Critical patent/EP1044139A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/005—Closures provided with linings or internal coatings so as to avoid contact of the closure with the contents

Definitions

  • the present invention relates to containers, such as baby bottles and cups, used for drinking purposes and closures for these articles.
  • a particular object in this area would be to improve sanitary conditions of containers used by children and babies for drinking purposes.
  • Typical among these are, for example, plastic baby bottles and drinking cups.
  • a typical baby bottle includes the bottle container itself and a closure formed by a rubber nipple and a collar of plastic material having a hole into which the nipple is inserted, with the collar being fastened to the container.
  • Another typical type of such container is a plastic cup having a closure in the form of a lid with a spout, with the lid being screwed or snapped onto the cup.
  • the plastic collar and the lid forming the closures are often made by injection molding.
  • Bacterial growth sites also can be produced by other liquids, such as fruit juices, formula, and even water. When the user drinks liquid from the bottle or cup, the liquid can come into contact with the bacteria, which can be transferred to the user. Accordingly, it would be desirable to attempt to eliminate the growth of such bacteria on such products, that is to make the sites incapable or less capable of supporting bacterial growth.
  • the present invention relates to closures of the type described above containing an inorganic antimicrobial agent, preferably a ceramic zeolite.
  • the container closures such as the collar for the baby bottles and the lids for the cups, are made with the antimicrobial agent incorporated into the plastic resin used for molding the closures.
  • a further object is to provide closures for baby bottle and juvenile drinking containers having an antimicrobial agent.
  • Still a further object is to provide plastic closures for drinking containers containing an inorganic antimicrobial agent which reduce the possibility of establishment of bacterial growth sites.
  • Fig. 1 is a perspective view of a collar for a baby bottle
  • Fig. 1 A is a plan view of an insert of antimicrobial material for a baby bottle collar
  • Fig. 2 is a perspective view of a drinking container and a lid therefore;
  • Fig. 3 is a view of the underside of the lid of Fig 2 showing a modified version thereof.
  • Fig. 3A is a cross-section of a ridge used for the underside of the lid of Fig. 3.
  • Fig. 1 shows a collar 10 of the type used as a part of a closure for the open end of a baby bottle (not shown) .
  • the collar 1 0 has a top wall 1 2 with a hole 14 through which the end of the nipple (not shown) is inserted.
  • the collar has a depending skirt wall 1 6 with threads on the inner wall thereof which are used to fasten the collar to the bottle with the nipple inserted.
  • the collar 10 is made of a plastic material such as, for example, polypropylene, by any suitable process, such as injection molding.
  • the flange of the nipple is held between the top end the bottle and the top wall 1 2 of collar.
  • Fig. 2 shows a portion of a conventional type of drinking cup 20 used by children.
  • the cup has a threaded upper end 22 onto which the internally threaded wall 28 of a lid 30 is to be screwed.
  • the lid 30 has a spout 32 which the child places in his/her mouth, tips the cup and drinks from it.
  • the lids 20 also are of plastic and are typically made by injection molding.
  • the lid is normally only rinsed in tap water, such that a film is present on these surfaces which can support the growth of bacteria. This is a particular problem in the spout area, which is hard to clean.
  • the collar and lid components are made of material that has antimicrobial properties. It is preferred that the plastic resin used for forming the components contains an inorganic antimicrobial agent.
  • a preferred inorganic antimicrobial agent that can be incorporated into a resin suitable for the products is an antibiotic zeolite.
  • Suitable zeolites and a method for incorporating them into the resin is disclosed in U.S. patent 4,938,955.
  • the resins can be those such as polyethylene, polypropylene, polystyrene, polyvinyl chloride, ABS resins and others disclosed in said patent.
  • the zeolite is kneaded into the resin and the composite of the resin and the zeolite are then processed, such as by injection molding, to form the articles 1 0 and 20 described above.
  • the agent is available on the potential bacteria growth sites of the surfaces of the articles, including the interior of the spout 32, to prevent the growth of bacteria, such as would be caused by milk and other liquids coming into contact with it.
  • antimicrobial agents are also suitable as described below and would be processed in the same manner with the resin.
  • the inorganic antimicrobial agent incorporated in the resin a number of metal ions, which are inorganic materials, have been shown to possess antibiotic activity, including silver, copper, zinc, mercury, tin, lead, bismuth, cadmium, chromium and thallium ions. These antibiotic metal ions are believed to exert their effects by disrupting respiration and electron transport systems upon absorption into bacterial or fungal cells.
  • Antimicrobial metal ions of silver, gold, copper and zinc, in particular, are considered safe even for in vivo use. Antimicrobial silver ions are particularly useful for in vivo use due to the fact that they are not substantially absorbed into the body.
  • the inorganic antibiotic metal containing composition is an antibiotic metal salt.
  • antibiotic metal salts include silver iodate, silver iodide, silver nitrate, and silver oxide. Silver nitrate is preferred. These salts are particularly quick acting, as no release from ceramic particles is necessary for antimicrobial function.
  • Antibiotic zeolites are preferred. These have been prepared by replacing all or part of the ion-exchangeable ions in zeolite with ammonium ions and antibiotic metal ions, as described in U.S. Patent Nos. 4,938,958 and 4,91 1 ,898. Such zeolites have been incorporated in antibiotic resins (as shown in U.S.
  • Patent Nos. 4,938,955 and 4,906,464) and polymer articles U.S. Patent No. 4,775,585).
  • Polymers including the antibiotic zeolites have been used to make refrigerators, dish washers, rice cookers, plastic film, chopping boards, vacuum bottles, plastic pails, and garbage containers.
  • Other materials in which antibiotic zeolites have been incorporated include flooring, wall paper, cloth, paint, napkins, plastic automobile parts, catheters, bicycles, pens, toys, sand, and concrete. Examples of such uses are described in US Patents 5,714,445; 5,697,203; 5,562,872; 5,1 80,585; 5,714,430; and 5, 102,401 .
  • Antibiotic ceramic particles useful with the present invention include zeolites, hydroxy apatite, zirconium phosphates or other ion-exchange ceramics. Zeolites are preferred, and are described in the preferred embodiments referred to below. Hydroxy apatite particles containing antimicrobial metals are described, e.g., in U.S. Patent No. 5,009,898. Zirconium phosphates containing antimicrobial metals are described, e.g., in U.S. Patent Nos. 5,296,238; 5,441 ,71 7; and 5,405,644.
  • Antibiotic zeolites are well-known and can be prepared for use in the present invention using known methods. These include the antibiotic zeolites disclosed, for example, in U.S. Patent Nos. 4,938,958 and 4,91 1 ,898.
  • Zeolite is an aluminosilicate having a three dimensional skeletal structure that is represented by the formula: XM j /nO-Al j Oa-YSiO j -ZHjO.
  • M represents an ion-exchangeable ion, generally a monovalent or divalent metal ion
  • n represents the atomic valency of the (metal) ion
  • X and Y represent coefficients of metal oxide and silica respectively
  • Z represents the number of water of crystallization.
  • zeolites examples include A-type zeolites, X-type zeolites, Y-type zeolites, T-type zeolites, high-silica zeolites, sodalite, mordenite, analcite, clinoptilolite, chabazite and erionite.
  • the present invention is not restricted to use of these specific zeolites.
  • These ion-exchange capacities are sufficient for the zeolites to undergo ion-exchange with ammonium and antibiotic metal ions.
  • the specific surface area of preferred zeolite particles is preferably at least 1 50 m 2 /g (anhydrous zeolite as standard) and the SiO 2 /AI 2 O 3 mol ratio in the zeolite composition is preferably less than 14, more preferably less than 1 1 .
  • the antibiotic metal ions used in the antibiotic zeolites should be retained on the zeolite particles through an ion-exchange reaction.
  • Antibiotic metal ions which are adsorbed or attached without an ion-exchange reaction exhibit a decreased bacteriocidal effect and their antibiotic effect is not long-lasting. Nevertheless, it is advantageous for imparting quick antimicrobial action to maintain a sufficient amount of surface adsorbed metal ion.
  • the antibiotic metal ions tend to be converted into their oxides, hydroxides, basic salts etc. either in the micropores or on the surfaces of the zeolite and also tend to deposit there, particularly when the concentration of metal ions in the vicinity of the zeolite surface is high. Such deposition tends to adversely affect the bactericidal properties of ion-exchanged zeolite.
  • a relatively low degree of ion exchange is employed to obtain superior bactericidal properties.
  • the zeolite particles retain metal ions having bactericidal properties at ion-exchangeable sites of the zeolite in an amount less than the ion-exchange saturation capacity of the zeolite.
  • the zeolite employed in the present invention retains antimicrobial metal ions in an amount up to 41 % of the theoretical ion-exchange capacity of the zeolite.
  • Such ion-exchanged zeolite with a relatively low degree of ion-exchange may be prepared by performing ion-exchange using a metal ion solution having a low concentration as compared with solutions conventionally used for ion exchange.
  • the antibiotic metal ion is preferably present in the range of from about 0.1 to 20wt.% of the zeolite.
  • the zeolite contains from 0.1 to 20wt.% of silver ions and from 0.1 to 20wt.% of copper or ⁇ zinc ions.
  • ammonium ion can be contained in the zeolite at a concentration of about 20 wt.% or less of the zeolite, it is desirable to limit the content of ammonium ions to from 0.5 to 1 5 wt.%, preferably 1 .5 to 5 wt.%.
  • Weight% described herein is determined for materials dried at temperatures such as 1 10°C, 250°C or 550°C as this is the temperature employed for the preferred post-manufacturing drying process.
  • a preferred antibiotic zeolite is type A zeolite containing either a combination of ion-exchanged silver, zinc, and ammonium or silver and ammonium.
  • One such zeolite is manufactured by Shinegawa, Inc. under the product number AW-10N and consists of 0.6% by weight of silver ion-exchanged in Type A zeolite particles having a diameter of about 2.5 ⁇ .
  • Another formulation, AJ-10N consists of about 2% by weight silver ion-exchanged in Type A zeolite particles having a diameter of about 2.5 ;.
  • Another formulation, AW-80 contains 0.6% by weight of silver ion-exchanged in Type A zeolite particles having a. diameter of about 1 .0 ⁇ .
  • Another formulation, AJ-80N consists of about 2% by weight silver ion-exchanged in Type A zeolite particles having a diameter of about 1 .O ⁇ . These zeolites preferably contain about between 0.5% and 2.5% by weight of ion-exchanged ammonium.
  • the zeolites are often obtained in master batches of low density polyethylene, polypropylene, or polystyrene, containing 20 wt.% of the zeolite.
  • thermoplastic materials for forming the composite resin used to make the articles of the invention.
  • the antibiotic particles are preferably present in a concentration by weight in the resin used to make the articles of from 0.01 to 10.0 wt%, more preferably from 0.01 to 8.0 wt%, and most preferably from 0.1 to 5.0 wt%.
  • the antibiotic properties of the antibiotic zeolite particles of the invention may be assayed while in aqueous formulations using conventional assay techniques, including for example determining the minimum growth inhibitory concentration (MIC) with respect to a variety of bacteria, eumycetes and yeast. In such a test, the bacteria listed below may be employed: Bacillus cereus var mycoides,
  • Penicillum funiculosum Candida a/bicans
  • the assay for determining MIC can be carried out by smearing a solution containing bacteria for inoculation onto a plate culture medium to which a test sample of the encapsulated antibiotic zeolite particles is added in a particular concentration, followed by incubation and culturing of the plate.
  • the MIC is defined as a minimum concentration thereof required for inhibiting the growth of each bacteria.
  • the antibiotic zeolites are exceptionally suitable under relevant toxicity and biocompatibility standards for use in the articles and are not adversely affected or deteriorated upon being contacted by beverages such as milk and fruit juices.
  • Fig. 1 A shows a product useful with a baby bottle in the form of an annular disk 50 having a central hole 52 made from the resin and antimicrobial agent mixture.
  • the mixture is formed into flat sheets which are then cut or punched to the desired shape.
  • the disks 50 also can be made by extrusion or other conventional processes.
  • the disk 50 is inserted against the inner surface of the collar upper wall 1 4.
  • the agent present in the disk performs the function of preventing bacteria growth, as explained above.
  • Fig. 3 shows the inner surface 35 of the lid 30 as having a plurality of ridges 37 disposed thereon.
  • the ridges 37 increase the available surface area of the antibiotic agent.
  • Fig. 3A shows the ridges 37 as being of generally triangular shape, although other suitable shapes can be used.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne une fermeture pour un récipient destiné à contenir des liquides, cette fermeture étant fabriquée à base d'une résine contenant un agent inorganique bactéricide pouvant entrer en contact avec le liquide.
EP19990955165 1998-10-29 1999-10-25 Fermetures plastiques bactericides pour recipients a boissons Withdrawn EP1044139A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18214698A 1998-10-29 1998-10-29
US182146 1998-10-29
PCT/US1999/025046 WO2000026100A1 (fr) 1998-10-29 1999-10-25 Fermetures plastiques bactericides pour recipients a boissons

Publications (2)

Publication Number Publication Date
EP1044139A1 true EP1044139A1 (fr) 2000-10-18
EP1044139A4 EP1044139A4 (fr) 2002-11-06

Family

ID=22667251

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19990955165 Withdrawn EP1044139A4 (fr) 1998-10-29 1999-10-25 Fermetures plastiques bactericides pour recipients a boissons

Country Status (4)

Country Link
EP (1) EP1044139A4 (fr)
AU (1) AU1133600A (fr)
CA (1) CA2316840A1 (fr)
WO (1) WO2000026100A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458109B1 (en) 1998-08-07 2002-10-01 Hill-Rom Services, Inc. Wound treatment apparatus
US20020012760A1 (en) * 1999-03-01 2002-01-31 John E. Barry Antimicrobial food tray
EP1233808B1 (fr) 1999-11-29 2008-07-09 Hill-Rom Services, Inc. Appareil de traitement de plaies
US6685681B2 (en) 2000-11-29 2004-02-03 Hill-Rom Services, Inc. Vacuum therapy and cleansing dressing for wounds
US6855135B2 (en) 2000-11-29 2005-02-15 Hill-Rom Services, Inc. Vacuum therapy and cleansing dressing for wounds
JP2004534595A (ja) 2001-07-12 2004-11-18 ヒル−ロム サービシズ，インコーポレイテッド 真空度変化率の制御
EP1478313B2 (fr) 2001-12-26 2018-03-07 KCI Medical Resources Pansement sous vide ventile
WO2003057071A2 (fr) 2001-12-26 2003-07-17 Hill-Rom Services, Inc. Emballage de pansement sous vide
AU2002360757A1 (en) 2002-02-28 2003-09-16 Hill-Rom Services, Inc. External catheter access to vacuum bandage
US7896856B2 (en) 2002-08-21 2011-03-01 Robert Petrosenko Wound packing for preventing wound closure
US7931651B2 (en) 2006-11-17 2011-04-26 Wake Lake University Health Sciences External fixation assembly and method of use
US8377016B2 (en) 2007-01-10 2013-02-19 Wake Forest University Health Sciences Apparatus and method for wound treatment employing periodic sub-atmospheric pressure
WO2008109442A2 (fr) 2007-03-02 2008-09-12 Rubbermaid Commercial Products Llc Station de changement
US8834520B2 (en) 2007-10-10 2014-09-16 Wake Forest University Devices and methods for treating spinal cord tissue
US10919672B2 (en) 2008-03-31 2021-02-16 Angelcare Feeding Usa, Llc Seal indication mechanism for containers
RU2544093C2 (ru) 2008-07-18 2015-03-10 Уэйк Форест Юниверсити Хелс Сайенсиз Устройство и способ модуляции сердечной ткани путем местного применения разряжения для минимизации гибели и повреждения клеток
US8365328B2 (en) 2008-08-06 2013-02-05 Bobrick Washroom Equipment, Inc. Baby changing station
USRE48480E1 (en) 2008-08-06 2021-03-23 Bobrick Washroom Equipment, Inc. Baby changing station
US8375490B2 (en) 2008-08-06 2013-02-19 Bobrick Washroom Equipment, Inc. Baby changing station
IT1401452B1 (it) 2010-06-10 2013-07-26 S M P S R L Contenitore e relativa chiusura per prodotti sterili e/o a bassa carica batterica privi di conservanti
BE1023272B1 (nl) * 2015-07-14 2017-01-19 Bepori Bvba Samenstelling van bacteriedodend rubber en gebruik in de veeteelt.
US10524598B2 (en) 2016-05-03 2020-01-07 Benny Green Easily cleanable drinking assembly
IT201900022509A1 (it) 2019-11-29 2021-05-29 Getters Spa Imballaggio alimentare per il controllo o la rimozione di ammine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485064A (en) * 1982-04-06 1984-11-27 Baxter Travenol Laboratories, Inc. Antibacterial seal
JPS59133235A (ja) 1983-01-21 1984-07-31 Kanebo Ltd 殺菌性ポリマー組成物及びその製造法
US4938958A (en) 1986-12-05 1990-07-03 Shinagawa Fuel Co., Ltd. Antibiotic zeolite
JPS63265958A (ja) 1987-04-22 1988-11-02 Shinagawa Nenryo Kk 抗菌性樹脂組成物
JPH0688885B2 (ja) 1987-12-26 1994-11-09 品川燃料株式会社 抗菌性粉体を含有する分散体の製造方法
US5009898A (en) 1988-09-29 1991-04-23 Kabushiki Kaisha Sangi Antimicrobial hydroxyapatite powders and methods for preparing them
US5102401A (en) 1990-08-22 1992-04-07 Becton, Dickinson And Company Expandable catheter having hydrophobic surface
US5296238A (en) 1991-02-26 1994-03-22 Toagosei Chemical Industry Co., Inc. Microbicides
JPH04339772A (ja) * 1991-05-09 1992-11-26 Toyo Seikan Kaisha Ltd ライナー付容器蓋及びその製造方法
US5180585A (en) 1991-08-09 1993-01-19 E. I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
KR970010904B1 (ko) 1992-05-20 1997-07-02 하찌구 쇼지 가부시끼가이샤 장기간 보존 가능한 도시락의 제조장치 및 도시락용기
JP3448896B2 (ja) 1992-05-21 2003-09-22 東亞合成株式会社 抗菌剤の製造方法
JP3201023B2 (ja) 1992-11-17 2001-08-20 東亞合成株式会社 抗菌性合成繊維の製造方法
JPH0896B2 (ja) 1993-02-16 1996-01-10 株式会社ダイキョー 抗菌まな板の製造方法
US5429628A (en) 1993-03-31 1995-07-04 The Procter & Gamble Company Articles containing small particle size cyclodextrin for odor control
DE4425278A1 (de) 1994-07-16 1996-01-18 Basf Ag Mischungen enthaltend Silber auf nicht zeolithischen Trägeroxiden

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0026100A1 *

Also Published As

Publication number Publication date
EP1044139A4 (fr) 2002-11-06
CA2316840A1 (fr) 2000-05-11
AU1133600A (en) 2000-05-22
WO2000026100A1 (fr) 2000-05-11

Similar Documents

Publication Publication Date Title
EP1044139A1 (fr) Fermetures plastiques bactericides pour recipients a boissons
EP1133327B1 (fr) Revetement polymere hydrophile antibiotique
US6582715B1 (en) Antimicrobial orthopedic implants
US20020012760A1 (en) Antimicrobial food tray
US6123925A (en) Antibiotic toothpaste
US6267590B1 (en) Antimicrobial dental products
WO2000064506A9 (fr) Extenseur pourvu d'un agent antimicrobien
WO2000038552A1 (fr) Boitier antimicrobien pour lentille de contact
CN106942959A (zh) 抗菌产品及其制造方法
WO2001034686A2 (fr) Produits mousse flexibles renfermant un agent antimicrobien inorganique, et procedes de fabrication y relatif
EP1124743B1 (fr) Courroie presentant un effet antimicrobien
WO2000051477A1 (fr) Napperon contenant un agent antimicrobien
US20020005194A1 (en) Cooking grill with antimicrobial agent
JP2846051B2 (ja) 抗菌性容器
WO2000064259A1 (fr) Glaciere a proprietes anti-microbiennes
US20140097660A1 (en) Antimicrobial furniture and method of making
WO2001037670A2 (fr) Dispositif a boucles et crochets antimicrobien
JP3476896B2 (ja) 抗菌性樹脂成形品およびその製造法
KR20040088007A (ko) 나노 실버가 함유된 박스
WO2001046900A9 (fr) Ecran tactile pourvu de proprietes antimicrobiennes
JP3046284U (ja) 抗菌性飲料用タンク
JPH0525503Y2 (fr)
CA2943163A1 (fr) Produit antibacterien renfermant du nitrate d'argent fritte et methodes de fabrication associees
JPH0977052A (ja) 抗菌飲料用紙器
JPH0621513U (ja) 抗菌性を有するスポンジ製品

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000629

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AGION TECHNOLOGIES, L.L.C.

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20021106

RIC1 Information provided on ipc code assigned before grant

Free format text: 7B 65D 81/28 A, 7B 65D 51/00 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010419